BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15847198)

  • 1. Medical technology management: bridging the gap between theory and practice.
    Shemer J; Abadi-Korek I; Seifan A
    Isr Med Assoc J; 2005 Apr; 7(4):211-5. PubMed ID: 15847198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of medical technologies.
    Seifan A; Shemer J
    Isr Med Assoc J; 2005 Feb; 7(2):67-70. PubMed ID: 15729952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economic evaluation of health technologies: theory and practice].
    Abadi-Korek I; Shemer J
    Harefuah; 2008 Jun; 147(6):509-11, 574. PubMed ID: 18693627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment (HTA): definition, role and use in the changing healthcare environment.
    Gallio D; Berto P
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():7-11. PubMed ID: 18924460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The implementation of innovative medical technologies: biological pharmaceuticals for the treatment of psoriasis--a case study].
    Tal O; Lomnicky Y
    Harefuah; 2012 Jun; 151(6):368-71, 376. PubMed ID: 22991870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for economic evaluations of health care technologies.
    Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Technology Assessment: managing the introduction and use of medical devices in clinical practice in Italy.
    Migliore A; Ratti M; Cerbo M; Jefferson T
    Expert Rev Med Devices; 2009 May; 6(3):251-7. PubMed ID: 19419283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priority setting and the ethics of resource allocation within VA healthcare facilities: results of a survey.
    Foglia MB; Pearlman RA; Bottrell MM; Altemose JA; Fox E
    Organ Ethic; 2008; 4(2):83-96. PubMed ID: 18839751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Year 2006 update of the Israel National List of Health Services.
    Tamir O; Rabinovich M; Shani M
    Isr Med Assoc J; 2006 Sep; 8(9):595-600. PubMed ID: 17058406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of best investing in vaccines: the Health Technology Assessment approach.
    La Torre G; de Waure C; Chiaradia G; Mannocci A; Specchia ML; Nicolotti N; Ricciardi W
    Vaccine; 2008 Mar; 26(13):1609-10. PubMed ID: 18289744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ending the technology paradox: healthcare management technologies for clinical decision making.
    Karys A
    J Healthc Inf Manag; 1998; 12(3):25-32. PubMed ID: 10338784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of technology on health care cost and policy development.
    Wallner PE; Konski A
    Semin Radiat Oncol; 2008 Jul; 18(3):194-200. PubMed ID: 18513629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of health technology assessment in the comprehensive evaluation of the impact of immunotherapy on real practice.
    Frati F; Ariano R; Cadario G; Ortolani C; Passalacqua G
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():4-6. PubMed ID: 18924459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.